Clinical Trials
PainReform conducted a Phase 2 study to evaluate PRF-110’s safety and efficacy in hernia repair surgeries at three Israeli medical centers.
prf-tech.comCrawled Nov 5, 2026
PainReform conducted a Phase 2 study to evaluate PRF-110’s safety and efficacy in hernia repair surgeries at three Israeli medical centers.
PRF-110 is a viscous, oil-based solution applied directly to surgical wounds for localized and prolonged post-operative pain relief.
PainReform develops PRF-110, an oil-based solution for localized, extended post-operative pain relief to reduce opioid dependence.
PRF Technologies’ extended delivery platform enables continuous drug release without intravenous access or frequent dosing, using an oil-based, viscous formulation.
PainReform exercised warrants to purchase up to 467,896 ordinary shares.
Acquisition Positions PainReform as a Potential Leader in High-Growth, High-Margin AI Solar Energy Management While Continuing Its Core Focus on Pharmaceutical Innovation Tel Aviv, Israel – March 5, 2024 – PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company“), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced the successful closing […]
The International Energy Agency projects global data center electricity use to double by 2030, with AI-focused centers tripling consumption. PRF Technologies believes its GridFeed AI optimization engine can help operators manage limited power capacity.
Investor relations from the press 09/02/2020 read more 06/18/2018 read more
Investor relations press releases 01/07/2021 read more 01/06/2021 read more 01/06/2021 read more 12/03/2020 read more 11/05/2020 read more 10/19/2020 read more
As of September 30, 2026, PRF Technologies held approximately $11 million in cash and $2.5 million in liabilities. The company plans to enroll patients in a U.S. Phase 2 trial for OcuRing-K and expand GridFeed’s growth initiatives.
PRF-110 demonstrated superior surface-tissue spreading properties compared to the industry leader in in vitro tests.
New studies show PRF-110 has superior in-vitro release rates for topical post-surgical pain management compared to the industry leader.
Ehud Geller, Ph.D., has over 30 years of experience in healthcare, biopharma, and life sciences, including as president and CEO of Interpharm Laboratories, Ltd.
Management Team & Board of Directors Management Team Ehud Geller, Ph.D. Executive Chairman & Interim CEO Dr. Ehud Geller has been active in the health care/biopharma and life science industries for over 30 years. The former president and CEO of Interpharm Laboratories, Ltd., he presided over the growth of this company from the seed stage […]
PRF Technologies develops specialty pharmaceutical therapies and AI-driven energy analytics, focusing on reformulated drugs and sustained-release delivery to reduce opioid reliance.
Investor relations GOVERNANCE OVERVIEW BOARD MEMBERS AUDIT COMMITTEE COMPENSATION COMMITTEE Efi Cohen Arazi – Chairman Gus Lawlor Ellen Baron GOVERNANCE DOCUMENTS read more read more read more
The global post-operative pain treatment market was valued at $12 billion in 2017 and is projected to exceed $45 billion by 2026, with unmet demand for long-acting local anesthetics.
Strategy Our first priority is to continue the drive toward commercialization of PRF-110. We plan to begin our pivotal Phase 3 clinical trials as we move toward an NDA approval for PRF-110: We have an amassed and extensive toxicology package for PRF-110, demonstrating that there were no PRF-110-related serious adverse events in either healthy subjects […]
Contact info 65 Yigal Alon St. Tel Aviv Po Box 68, Israel 6744316 Phone: +972-3-7177051 Email: info@prf-tech.com Investor Relations Crescendo Communications, LLC 12 E. 49th Street, 18th Floor New York, NY 10017 Phone: +1-212-671-1020 Email: PRFX@crescendo-ir.com
PRF Technologies applies unique technologies to extend drug efficacy and patient comfort, and uses AI analytics to maximize solar power value.
PainReform’s Privacy Policy outlines how it collects, uses, and shares user data in compliance with privacy regulations.
Accessibility Statement Updated as of 24/02/2026 PRF – Technologies makes the utmost in its ability and invests many resources in order to provide all its clients with an equal, dignified, accessible and professional service. In accordance with the Law of Equal Rights for People with Disabilities 1998 and the regulations established thereupon, many efforts and […]